Факторы риска хронической обструктивной болезни легких

1. Баранов B.C., Баранова Е.В., Иващенко Т.Э., Асеев М.В. Геном человека и гены "предрасположенности". (Введение в предиктивную медицину). СПб: Интермедицина; 2000.

2. Способ прогнозирования развития обструктивного синдрома у больных хроническим бронхитом с учетом наследственных факторов. Метод. Рекомендации / Ивчик Т.В., Кокосов А.Н., Разоренов Г.И. и др. СПб: ГНЦП М3 РФ; 1998.

3. Роль наследственных факторов в прогнозировании риска развития бронхообструктивного синдрома в семьях больных хроническим бронхитом: Пособие для врачей / Ивчик Т.В., Кокосов А.Н., Разоренов Г.И. и др. СПб: НИИ пульмонологии ГМ У им.акад.И.П.Павлова; 2001.

4. Ивчик Т.В., Кокосов А.Н., Разоренов Г.И. и др. Прогнозирование развития обструктивного синдрома у больных хроническим бронхитом с учетом наследственных факторов. Тер. арх. 2001; 3: 33-37.

5. Разоренов Г.И., Поддубский Г.А. Автоматизированная оценка и анализ состояния организма (медицинская статусметрия). Л.: Препринты ЛИИАН; 1985; ч.1-2.

6. Ткаченко Г.Б. Сколько мы платим за табак. К всемирному Дню без табачного дыма — 31 мая 1995 года. Данные Всемирной организации здравоохранения. В кн.: Серия докладов по политике в области охраны здоровья населения "Здоровье для всех — Все для здоровья в России"/ Под ред. А.К.Демина. М.; 1996. 28-155.

7. Ткаченко Г.Б. О ситуации, связанной с курением табака в России. Нижегород. мед. журн. 1998; 1: 7-10.

8. Хоменко А.Г. (ред.) Проблемы наследственности при болезнях легких. М.: Медицина; 1990.

9. Чучалин А.Г. Болезни курящего человека. Тер. арх. 1998; 3: 5-13.

10. Чучалин А.Г. Эмфизема. В кн.: Хронические обструктивные болезни легких. М.: ЗАО "Изд-во БИНОМ"; СПб.: Невский Диалект; 1998. 6-13.

11. Чучалин А.Г. Тяжелые формы бронхиальной астмы. Тер. арх. 2001; 3; 5-9.

12. Чучалин А.Г. Клинические рекомендации по хронической обструктивной болезни легких. / Под ред. Н.Хмельковой. М.: НИИ пульмонологии М3 РФ; 2001.

13. Anto J.M., Sunyer Vermeire P., Vestbo J. Epidemiology of chronic obstructive pulmonary disease. Eur. Respir. J. 2001; 17(5): 982-994.

14. Attfield M.D., Hodous Т.К. Pulmonary function of US coal miners related to dust exposure estimates. Am. Rev. Respir. Dis. 1992; 145: 605-609.

15. Bakke P.S., Baste V., Gulsvik A. Bronchial responsiveness in a Norwegian community. // Ibid. 1991; 143: 317-322.

16. Bakke P.S., Baste V., Hanoa R., Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some aitborne agents. Thorax 1991; 46: 863-870.

17. Bakke P .S., Hanoa R., Gulsvik A. Educational level and obstructive lung disease given smoking habits and occupational airborne exposure: a Norwegian community study. Am. J. Epidemiol. 1995; 141: 1080-1088.

18. Bascom R. Differential susceptibility to tobacco smoke: possisble mechanisms. Pharmacogenetics 1991; 1: 102-106.

19. Bast A ., Haenen G.R.M .M ., Doelman C.J.A. Oxidants and antioxidants: state of the art. Am. J. Med. 1991; 91: 2-13.

20. Britten N ., Davies J.M.C., Colley J.R.T. Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. Br. Med. J. 1987; 294: 1317-1320.

21. Butland B.K., Fehily A.M ., Elwood P.C. Diet, lung function, and lung function decline in a cohort of 2512 middle aged men. Thorax 2000; 55 (10): 2108.

22. Camili A.E., Burrows B., Knudson R.J. et al. Longitudinal changes in forced expiratiry volume in one second in adalts. Am. Rev. Respir. Dis. 1987; 135: 794-799.

23. Cantin A., Crystal R.G. Oxidants, antioxidants and the pathogenesis of emphisema. Eur. J. Respir. Dis. 1985; 66: 7-17.

24. Carrozzi L. et al. Family history for chronic lung disease and epidemiological determinants of COPD in three European Countriae. ERS Rev. 2001; 11 (80): 49-54.

25. Carta P., Aru G.X., Barbieri M .T. et al. Dust exposure, respiratory symptoms, and longitudinal decline of lung function in young coal miners. Occup. Environ. Med. 1996; 53: 321-319.

26. Chen L., Yang W., Jennison B.L., Omaye S.T. Air particulate pollution and hospital admissions for chronic obstructive pulmonary disease in Reno, Nevada. Inhal. Toxicol. 2000; 12 (4): 281-298.

27. Chen Y., Horne S.L., Dosman J.A. Increased susceptibility to lung dysfunction in female smokers. Am. Rev. Respir. Dis. 1991; 143: 1224-1230.

28. Chen Y., Breithaupt K., M uhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J. Clin. Epidemiol. 2000; 53 (7): 755-761.

29. Confronting COPD in North America and Europe A survey of patients and doctors in eight countries: Executive Summary. 2001.

30. Dalphin J.C., Polio J.C., Pernet D. et al. Influence of barn drying of folder on respiratory symptoms and function in dairy farmers of the Doubs region of France. Thorax 1994; 49: 50-53.

31. Editorial. Fish oil. Lancet 1988; 1 (8594): 1081-1083.

32. Godoy I., Castro de Silva M.H., Togashi R.H. et al. Is chronic hypoxemia in patients with chronic obstructive pulmonary disease associated with more marked nutritional deficiency? A study of the fat-free mass evaluated by anthropometry and bioelectrical impedance methods. J. Nutr. Hlth Aging 2000; 4 (2): 102-108.

33. Hnizdo E. Loss of lung function associated with exposure to silica dust and with smoking and its relation to disability and mortality in South African gold minners. Br. J. Industr. Med. 1992; 49: 472-479.

34. Hoffman P., Mest H.J. What about the effects of dietary lipids on endogeneous prostanoid systhesis? A state-of-the-art review. Biomed. Biochim. Acta 1987; 7: 639-650.

35. Hubert H.B., Fabsitz R.R., Feinleib M, Gwinn C. Genetic and environmental influences on pulmonary function in adult twins. Am. Rev. Respir. Dis. 1982; 125: 409-415.

36. Ivtchik T., Mkheidze M ., Kokosov A. et al. The research for genetic marcers of predisposition to chronic bronchitis (CB). Eur. J. Hum. Genet. 1996; Apr.: Absracts of the 28th meeting of the ESHG (Lond.) 9.097 (P. 140).

37. Kauffmann F., Drouet D., Lellouch J., Brille D. Occupational exposure and 12-yr spirometric changes among Paris area workers. Br. J. Industr. Med. 1982; 39: 221-232.

38. Kerstens H .A.M ., Rijcken B., Schouten J.P., Postma D.S. Decline of FEV| by age and smoking status: facts, figures and fallacies. Thorax 1997; 52: 820-827.

39. Krzizanowski AL, Jedrychowski W., Wysocki M. Occupational exposures and changes in pulmonary function over 13 years among residents of Cracow. Br. J. Industr. Med. 1988; 45: 747-754.

40. Lewis S., Bekket J., Richards K., Britton J. A cross sectional study of the independent effect of occupation on lung function in British coal minners. Occup. Environ. Med. 1996; 53: 125-128.

41. Lomas D.A., Silverman E.K. The genetics of chronic obstructive pulmonary disease. Respir. Res. 2001; 2 (1): 20-26.

42. Maier K.L. How the lung deals with oxidants. Eur. Respir. J. 1993; 6: 334-336.

43. Martinez F.D., Morgan W.J., Wright A.L. et al. Initial airway function is a risk factor for recurrent wheezing respiratory illnesses during the fist three years of life. Am. Rev. Respir. Dis. 1991; 143: 312-316.

44. Mayer A .S., Newman L.S. Genetic and environmental modulation of chronic obstructive pulmonary disease. Respir. Physiol. 2001; 128(1): 3-11.

45. Menezes A.M .B., Victora C.G., Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a populationbased study. Thorax 1994; 49: 1217-1221.

46. Nejjari C., Tessier J.F., Dartigues J.F. et al. The relationship between dyspnoea and main lifetime occupation in the elderly. Int. Epidemiol. 1993; 22: 848-854.

47. Omenaas E., Bakke P., Eide G.E. et al. Total serym IgE and FEV| by respiratory symptoms and obstructive lung disease in adults of a Norwegian community. Clin. Exp. Allergy 1995; 25: 682-689.

48. Packer J.E., Slater T.F., Willson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature 1979; 278: 737-738.

49. Post W.K., Heederik D., Kromhout H., Kromhout D. Occupational exposures estimated by a population specific job exposure matrix and 25 year incidence rate of chronic nonspecific lung disease (CNSLD) — The Zutphen study. Eur Respir. J. 1994; 7: 1048-1055.

50. Prescott E., Bjerg A.M ., Andersen P.K. et al. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Ibid. 1997; 10 (4): 822-827.

51. Prescott E., Lange P., Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Ibid. 1999; 13 (5): 1109—1114.

52. Prescott E., Lange P., Vestbo J. Socioeconomic status, lung function and chronic obstructive pulmonary disease. Thorax, 2000; 54: 737-741.

53. Rijcken B., Britton J. Epidemiology of chronic obstructive pulmonary disease. / Management of chronic obstructive pulmonary disease. Eur. Respir. Monograph. 1998; 3(7): 41-73.

54. Sandford A.J., Weir T.D., Pare P.D. Genetic risk factors for chronic obstructive pulmonary disease. Eur. Respir. J. 1997- 10-1380-1391.

55. Sandford A.J., Pare P.D. Genetic risk factors for chronic obstructive pulmonary disease. Clin. Chest Med. 2000; 21 (4)- 633-643.

56. Satterthwaite S.J. The right time to give up. Advising women on smoking in pregnancy. Prof. Nurse 1993; 8 (4): 244-246.

57. Schwartz J., Weiss S.T. Relationship between dietary vitamin С intake and pulmonary function in the First National Health and Nutrition Examination Survey (NHANES I). Am. J. Clin. Nutr. 1994; 59: 110-114.

58. Schwartz J. Role of polyunsaturated fatty acids in lung disease. Ibid. 2000; 71(suppl.): 393-396.

59. Sherrill D.L., Lebowitz M.D. et al. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am. J. Respir. Crit. Care Med. 1995; 152: 98-102.

60. Sibile V., Reynolds H.Y. Macrophages and polymophonuclear neutrophils in lung disease and injury. Am. Rev. Respir. Dis. 1990; 141: 471-501.

61. Silverman E.K. Genetics of chronic obstructive pulmonary disease. Novartis Found. Symp. 2001; 234: 45-58; discus. 58-64.

62. Smid Т., Heederik D., Houba R., Quanjer P.H. Dust and endotoxin-related respiratory effects in the animal feed industry. Am. Rev. Respir. Dis. 1992; 146: 1474-1479.

63. Smit H.A., Grievink L., Tabak C. Dietary influences on chronic obstructive lung disease and asthma: a review of the epidemiological evidence. Proc. Nutr. Soc. 1999; 58 (2): 309-319.

64. Smit H.A., Ocke M.C., Heederik D. et al. Diet and chronic obstructive pulmonary disease: independent beneficial effects of fruits, whole grains, and alcohol (the M ORGEN study). Clin. Exp. Allergy 2001; 31 (5): 747-755.

65. Snider G.L. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Ann. Rev. Med. 1989; 40: 411-429.

66. Snider G.L. Emphysema: the first two centuries and beyond. Am. Rev. Respir. Dis. 1992; 146: 1615-1622.

67. Soyseth V., Kongerud J., Boe J. Postnatal maternal smoking increases the prevalence of asthma but not of bronchial hyperresponsiveness or atopy in their children. Chest 1995; 107(2)-389-394.

68. Stein C.E., Kumaran K., Fall C.H. et al. Relation of fetal growth to adult lung function in south India. Thorax 1997; 52: 895-899.

69. Tabak C., Smit H.A., Rasanen L. et al. Dietary factors and pulmonary function: a cross sectional study in middle aged men from three European countries. Ibid. 1999; 54: 1021-1026.

70. Tabak C., Arts I.C., Smit H.A. et al. Chronic obstructive pulmonary disease and intake of catechins, flavonols, and flavones: the MORGEN Study. Am. J. Respir. Crit. Care Med. 2001; 164 (1): 61-64.

71. Tager I.B., Hanrahan J.P., Tosteson T.D. et al. Lung function, pre- and postnatal smoke exposure, and wheezing in the first year of life. Am. Rev. Respir. Dis. 1993; 147: 811-817.

72. Viegi G., Prediletto R., Paoletti P. et al. Respiratory effects of occupational exposure in a general population sample in north Italy. Ibid. 1991; 143 (3): 510-515.

73. Xu X., Weiss S .Т., Rijcken B., Schouten J.P. Smoking changes in smoking habits, and rate of decline in FEVj: new insight into gender differences. Eur. Respir. J. 1994; 7: 1056-1061.

74. Young S., Arnott J., Le Souef P.N., Landau L.I. Flow limitation during tidal expiration in symptom-free infants and the subsequent development of asthma. J. Paediatr. 1994; 124(5, pt 1)-681-688.